跳至主要内容
临床试验/ACTRN12610000497000
ACTRN12610000497000已完成未知

Impact of a weight and risk factor management program in overweight and obese patients, on atrial fibrillation burden.

The University of Adelaide0 个研究点目标入组 800 人开始时间: 2010年6月16日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
800

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
21 Years 至 75 Years(—)
性别
All

入选标准

  • Inclusion criteria were: symptomatic paroxysmal or persistent AF; BMI (kgm-1)>27; waist circumference (cm) >100 (male) or >90 (females); and age 21-75 years.

排除标准

  • Inability to give informed consent, significant (moderate-severe) valvular heart disease, moderate-severe left ventricular systolic dysfunction/moderate-severe cardiomyopathy, renal impairment, significant gastrointestinal/mal-absorptive disorder, vitamin and trace element deficiency, insulin-dependent diabetes mellitus, uncontrolled underlying significant medical condition, unstable INR, significant endocrinopathy and recent participation (3 months) in a structured weight loss program.

研究者

相似试验